Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Lab7 Systems Launches BioBuilds, SeqSigma, and DashO3 to Accelerate and Streamline Genomic Data Processing

Published: Wednesday, September 04, 2013
Last Updated: Wednesday, September 04, 2013
Bookmark and Share
Free software and new services reduce dependencies and improve genomic workflow processes.

Lab7 Systems, Inc., announced that it has released a free software toolkit and new service offerings for the next-generation DNA sequencing (NGS) bioinformatics community, along with the latest beta version of its Lab7 Dashboard.  BioBuildsTM is a reference collection of Open Source bioinformatics tools for genomics, pre-built for Linux and Mac OS X platforms.  It eliminates the need for users to maintain and build their own versions of these tools.  By providing binaries, BioBuilds also enables users to easily reproduce results by removing version dependencies on underlying software, since all tools in BioBuilds will be pre-built for those binaries.

"Open Source software is important for bioinformatics", said Chris Mueller, Ph.D., Lab7 Systems’ President and Chief Technology Officer.  "However, building and maintaining Open Source tools can be a time consuming process.  We maintain internal builds of many analytical tools and we feel that making our builds freely available is a good way to give back to the genomics community."

BioBuilds is being released in conjunction with the second Public Beta of the Lab7 Dashboard, the company’s comprehensive software platform for managing sequencing projects, workflows, and pipelines.  This release includes the Production Pipeline Engine, a complete sequence analysis pipeline management and report generation system.  The Production Pipeline Engine allows users to easily port existing analysis pipelines into a managed, production-ready environment.  All BioBuilds tools are made readily available in the Lab7 Dashboard, even though the platform is not expressly required to run the tools.

Lab7 Systems also launched its SeqSigmaTM and DashO3TM optimization processes, integral components of the company’s larger suite of custom services.  The SeqSigma process utilizes clients’ sequencing and analysis goals to design and implement cost-effective computational infrastructures that scale with their labs, while the DashO3 pipeline optimization process identifies computational and dataflow bottlenecks in sequence analysis pipelines and can increase performance by two- to tenfold.

“Everything we’re launching today supports our vision of a streamlined environment for the management and analysis of NGS data,” concluded Dr. Mueller.  “With the tools we’re providing, we know that we can reduce the burden on bioinformaticians, scientists, and clinicians, allowing them to refocus their efforts to accelerate scientific discovery and clinical diagnoses.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Finding Links and Missing Genes
A catalogue of large-scale genetic changes around the world.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos